| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | EP0921800B1 Substituted biphenyl isoxazole sulfonamides |
| 04/14/2004 | EP0892790B1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use |
| 04/14/2004 | EP0839149B1 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 04/14/2004 | EP0839041B1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 04/14/2004 | EP0765392B1 Interleukin-5 specific recombinant antibodies |
| 04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
| 04/14/2004 | CN1489628A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 04/14/2004 | CN1489591A Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 04/14/2004 | CN1489585A Process for producing substituted 2-(2-pyridylmethye)sulfinye-1H-benzinmidazoles |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489580A Imidazole derivatives |
| 04/14/2004 | CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/14/2004 | CN1489573A Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 04/14/2004 | CN1489473A Silensed anti-CD 28 antibodies and use thereof |
| 04/14/2004 | CN1489472A Improved mycoplasma hyopneumoniae bacterin vaccine |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1489461A 甘油三酸酯降低剂组合物 Triglyceride lowering agent composition |
| 04/14/2004 | CN1489459A Use of 2-amino-1 (4-hydroxy-2-methanesu/phonamidophenyl) ethanol for treating urinary incontinence |
| 04/14/2004 | CN1488624A Novel substituted propanamide benzoyl urea derivatives, medicinal composition containg same and use thereof |
| 04/14/2004 | CN1488401A Use of preparing medicine for treating respiratory and cyclic failure |
| 04/14/2004 | CN1488365A Composition with intelligence-development, immunological regulation and fatigure resistance |
| 04/14/2004 | CN1145694C Novel human thrombopoietin mutein |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145627C Pyrazolo [4,3-d] pyrimidines |
| 04/14/2004 | CN1145623C Imidazole derivatives |
| 04/14/2004 | CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same |
| 04/14/2004 | CN1145618C Cycloformate derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145612C New 1-aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 04/14/2004 | CN1145610C Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145496C Novel formulation for peptide release |
| 04/14/2004 | CN1145489C Inositol polyphosphate derivatives and mthod of using same |
| 04/14/2004 | CN1145486C Pharmaceutical compositions containing eletriptan hemisulphate and coffeine |
| 04/14/2004 | CN1145485C 8-chloro-6,11-dihydro-11-(4-piperidy lidene)-5H-benzo[5,6] cyclohepta [1,2,-b] pyridine oral compositions |
| 04/14/2004 | CN1145481C Use of thiazolidinone in preparing medicine for treating and preventing neudrodegenerative disorders |
| 04/14/2004 | CN1145478C Pharmaceutical aerosol formulation |
| 04/13/2004 | US6720427 Used to treat abnormal cell growth and central nervous system disorders |
| 04/13/2004 | US6720424 Vegf (vascular endothelial growth factor) receptor antagonists and angiogenesis inhibitors suppress vascular hyperpermeability; phenylalkylcarbonyl substituent on the amino |
| 04/13/2004 | US6720357 Sulfonamide derivatives |
| 04/13/2004 | US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents |
| 04/13/2004 | US6720350 Reducing diminution in vessel lumen area with a therapeutic shunt having a cytoskeletal inhibitor to reduce stenosis or restenosis; taxols, cytochalasins |
| 04/13/2004 | US6720348 For therapy of diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic retinopathy, diabetic microangiopathy, diabetic macroangiopathy, cataracts and foot ulcers |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720337 Antitumor agents; synergistic mixtures; side effect reduction |
| 04/13/2004 | US6720332 Oxindole derivatives |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720320 Phenoxypropylamine compounds |
| 04/13/2004 | US6720318 Combination of cyamemazine and an atypical neuroleptic |
| 04/13/2004 | US6720316 Therapeutic 5-HT ligand compounds |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6720306 Drug delivery, antitumor agents |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/13/2004 | US6719960 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 04/13/2004 | US6718910 Agents for promoting fattening of animals and method of promoting fattening |
| 04/13/2004 | CA2322963C Methods to increase white blood cell survival after chemotherapy |
| 04/13/2004 | CA2311122C Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 04/13/2004 | CA2292248C Novel derivatives of 1,2-dithiolane, process for preparing them and pharmaceutical compositions containing them |
| 04/13/2004 | CA2185983C Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 04/13/2004 | CA2182397C Endotoxin reduction or removal process |
| 04/13/2004 | CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/11/2004 | WO2004033703A1 Novel macrophage foam cell formation inhibitor fka-25 and process for producing the same |
| 04/11/2004 | CA2461942A1 Novel fka-25 substance having inhibitory action against formation of the foam macrophage and a process for production thereof |
| 04/08/2004 | WO2004029624A1 Diagnostic and examination method for eating disorder |
| 04/08/2004 | WO2004029281A2 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 04/08/2004 | WO2004029058A1 Medicinal composition for inhibiting increase in blood gastrin concentration |
| 04/08/2004 | WO2004029056A1 [1,2,4]-TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVE |
| 04/08/2004 | WO2004029054A1 Novel adenine compound and use thereof |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029018A1 Glycerol derivative |
| 04/08/2004 | WO2004028567A1 Drug absorbability improving agents |
| 04/08/2004 | WO2004028561A1 Method of inducing immune responses |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004028557A1 Stabilized protein compositions |
| 04/08/2004 | WO2004028556A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 04/08/2004 | WO2004028545A1 A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
| 04/08/2004 | WO2004028531A1 Preventive or remedy for bedsore |
| 04/08/2004 | WO2004028528A1 Amino acid compositions for improving central functions |
| 04/08/2004 | WO2004028524A1 Combination drug |
| 04/08/2004 | WO2004028523A1 Particulate product comprising pantethine |
| 04/08/2004 | WO2004028520A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 04/08/2004 | WO2004028518A1 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 04/08/2004 | WO2004016580A3 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 04/08/2004 | WO2004011637A3 Modified adamts4 molecules and method of use thereof |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/08/2004 | WO2004004599A3 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |